Stribild Prices, Coupons and Patient Assistance Programs
Stribild (cobicistat/elvitegravir/emtricitabine/tenofovir) is a member of the antiviral combinations drug class and is commonly used for HIV Infection.
The cost for Stribild oral tablet (150 mg-150 mg-200 mg-300 mg) is around $4,202 for a supply of 30 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Stribild is available as a brand name drug only, a generic version is not yet available. View generic Stribild availability for more details.
Stribild prices
Oral Tablet
Quantity | Per unit | Price |
---|---|---|
30 | $140.06 | $4,201.72 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Stribild Coupons, Copay Cards and Rebates
Stribild offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Stribild Advancing Access Co-pay Program
Eligible commercially insured patients may save up to a maximum of $6000 per year with no monthly limits; for additional information contact the program at 800-226-2056.
- Applies to:
- Stribild
- Number of uses:
- per prescription per year
Form more information phone: 800-226-2056 or Visit website
Stribild Advancing Access Co-pay Program Direct Member Reimbursement
Eligible commercially insured patients may be eligible for reimbursement if they were enrolled in the Co-pay Program but paid in full out of pocket for their medication; for additional information contact the program at 800-226-2056.
- Applies to:
- Stribild
- Number of uses:
- One rebate per prescription fill
Form more information phone: 800-226-2056 or Visit website
Patient Assistance & Copay Programs for Stribild
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Advancing Access Program
Eligibility requirements:- Must be uninsured or underinsured
- At or below 500% of FPL
- Medically appropriate condition/diagnosis
- Must be residing in the US or Puerto Rico
- This program is for outpatient use only. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. This Program participates in the CPAPA. This single common application allows uninsured HIV-positive individuals with low incomes to use one application to apply for multiple assistance programs. *IMPORTANT: Send completed CPAPA to the corresponding addresses listed for each company.
- Stribild (elvitegravir-cobicistat-emtricitabine-tenofovir disoproxil fumarate) Tablet
More information please phone: 800-226-2056 Visit Website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Stribild (elvitegravir-cobicistat-emtricitabine-tenofovir disoproxil fumarate) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: Good Days Program
Eligibility requirements:- Must have insurance
- At or below 500% of FPL
- FDA-approved diagnosis
- The patient must also be a US resident with a Social Security Number.
- Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
- Stribild (elvitegravir-cobicistat-emtricitabine-tenofovir disoproxil fumarate) Tablet
More information please phone: 877-968-7233 Visit Website
More about Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- Check interactions
- Compare alternatives
- Reviews (90)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
- En español